PARAMETRIC PORTFOLIO ASSOCIATES LLC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q1 2022$5,881,000
-31.5%
143,222
-27.5%
0.00%
-25.0%
Q4 2021$8,588,000
+38.3%
197,572
+59.3%
0.00%0.0%
Q3 2021$6,210,000
-26.7%
124,022
-7.8%
0.00%
-20.0%
Q2 2021$8,475,000
-40.0%
134,540
-11.5%
0.01%
-37.5%
Q1 2021$14,118,000
+2.9%
151,954
-0.7%
0.01%
-11.1%
Q4 2020$13,714,000
-20.2%
153,061
-7.9%
0.01%
-25.0%
Q3 2020$17,178,000
+22.2%
166,248
-6.5%
0.01%
+9.1%
Q2 2020$14,056,000
+28.8%
177,738
-5.8%
0.01%
+10.0%
Q1 2020$10,914,000
+7.7%
188,626
+0.4%
0.01%
+42.9%
Q4 2019$10,134,000
+9.9%
187,842
+6.5%
0.01%0.0%
Q3 2019$9,221,000
+19.1%
176,378
+10.1%
0.01%
+16.7%
Q2 2019$7,741,000
-31.6%
160,231
-28.5%
0.01%
-40.0%
Q1 2019$11,320,000
-24.2%
224,069
-11.1%
0.01%
-33.3%
Q4 2018$14,936,000
-14.9%
251,959
-5.5%
0.02%0.0%
Q3 2018$17,555,000
+46.4%
266,670
+12.3%
0.02%
+36.4%
Q2 2018$11,989,000
-4.0%
237,453
+0.1%
0.01%
-8.3%
Q1 2018$12,495,000
+21.3%
237,330
+7.0%
0.01%
+20.0%
Q4 2017$10,303,000
+57.3%
221,719
+36.9%
0.01%
+42.9%
Q3 2017$6,549,000
+37.6%
161,898
+15.4%
0.01%
+16.7%
Q2 2017$4,759,000
+19.2%
140,349
+2.1%
0.01%0.0%
Q1 2017$3,994,000
-32.6%
137,528
-23.8%
0.01%
-25.0%
Q4 2016$5,928,000
+7.0%
180,522
+2.7%
0.01%0.0%
Q3 2016$5,542,000
-5.7%
175,782
-15.9%
0.01%
-11.1%
Q2 2016$5,879,000
-29.1%
209,071
-8.3%
0.01%
-30.8%
Q1 2016$8,287,000
+63.2%
227,989
+79.7%
0.01%
+44.4%
Q4 2015$5,077,000
+47.0%
126,905
+4.7%
0.01%
+28.6%
Q3 2015$3,454,000
-22.1%
121,251
-9.9%
0.01%
-22.2%
Q2 2015$4,436,000
+5.7%
134,623
-7.8%
0.01%
+12.5%
Q1 2015$4,197,000
+15.3%
145,942
+9.2%
0.01%0.0%
Q4 2014$3,639,000
+37.5%
133,634
+7.6%
0.01%
+33.3%
Q3 2014$2,647,000
-2.9%
124,193
+2.3%
0.01%0.0%
Q2 2014$2,727,000
+15.3%
121,408
+29.7%
0.01%0.0%
Q1 2014$2,366,000
+29.8%
93,634
+18.1%
0.01%
+50.0%
Q4 2013$1,823,000
+46.0%
79,315
+21.0%
0.00%
+33.3%
Q3 2013$1,249,000
+44.6%
65,542
+9.4%
0.00%0.0%
Q2 2013$864,00059,9060.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders